Journal of Neurochemistry

Journal

Publication Venue For

  • Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson's disease.  144:691-709. 2018
  • Haplodeficiency of Cathepsin D does not affect cerebral amyloidosis and autophagy in APP/PS1 transgenic mice.  142:297-304. 2017
  • How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?.  131-155. 2016
  • Rho-associated protein kinase 1 (ROCK1) is increased in Alzheimer's disease and ROCK1 depletion reduces amyloid-β levels in brain.  525-531. 2016
  • Involvement of aberrant cyclin-dependent kinase 5/p25 activity in experimental traumatic brain injury.  317-327. 2016
  • Bioenergetic adaptation in response to autophagy regulators during rotenone exposure.  131:625-633. 2014
  • Over-expression of an inactive mutant cathepsin D increases endogenous alpha-synuclein and cathepsin B activity in SH-SY5Y cells.  128:950-961. 2014
  • Peptidylarginine deiminases: Novel drug targets for prevention of neuronal damage following hypoxic ischemic insult (HI) in neonates.  130:555-562. 2014
  • Removing the blinkers: Moving beyond striatal dopamine in Parkinson's disease.  125:639-641. 2013
  • Neuromodulation: Selected approaches and challenges.  124:436-453. 2013
  • A mutation in CLOCK leads to altered dopamine receptor function.  123:124-134. 2012
  • Glial cells in (patho)physiology.  121:4-27. 2012
  • Organophosphates dysregulate dopamine signaling, glutamatergic neurotransmission, and induce neuronal injury markers in striatum.  119:303-313. 2011
  • Age-dependent spatial segregation of synaptobrevin 2-containing vesicles in astrocytes.  116:909-915. 2011
  • A neuroprotective role for angiogenin in models of Parkinson's disease.  116:334-341. 2011
  • GFR α-1 receptor expression in the aging nigrostriatal and mesoaccumbens pathways.  115:707-715. 2010
  • Contributions of poly(ADP-ribose) polymerase-1 and -2 to nuclear translocation of apoptosis-inducing factor and injury from focal cerebral ischemia.  113:1012-1022. 2010
  • Basal ganglia pathology in schizophrenia: Dopamine connections and anomalies.  113:287-302. 2010
  • Function of dopamine transporter is compromised in DYT1 transgenic animal model in vivo.  113:228-235. 2010
  • Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction.  114:1193-1204. 2010
  • ROLE OF SOCS PROTEINS IN GLIAL CELL FUNCTION.  110:212-212. 2009
  • Manganese exposure is cytotoxic and alters dopaminergic and GABAergic neurons within the basal ganglia.  110:378-389. 2009
  • In vitro glutaminase regulation and mechanisms of glutamate generation in HIV-1-infected macrophage.  109:551-561. 2009
  • A novel molecule 'shati' increases dopamine uptake via the induction of tumor necrosis factor-α in pheochromocytoma-12 cells.  107:1697-1708. 2008
  • Striatal histone modifications in models of levodopa-induced dyskinesia.  106:486-494. 2008
  • HIV-infected macrophages mediate neuronal apoptosis through mitochondrial glutaminase.  105:994-1005. 2008
  • Expression and function of SOCS proteins in astrocytes.  104:10-10. 2008
  • Differential regulation of the Cdk5-dependent phosphorylation sites of inhibitor-1 and DARPP-32 by depolarization.  103:1582-1593. 2007
  • Nuclear factor-κB regulates seizure threshold and gene transcription following convulsant stimulation.  103:1381-1395. 2007
  • Vesicular release of glutamate mediates bidirectional signaling between astrocytes and neurons.  103:1273-1284. 2007
  • Dopamine D1 and D3 receptors oppositely regulate NMDA- and cocaine-induced MAPK signaling via NMDA receptor phosphorylation.  103:840-848. 2007
  • Role of matrix metalloproteinase and tissue inhibitor of MMP in methamphetamine-induced behavioral sensitization and reward: Implications for dopamine receptor down-regulation and dopamine release.  102:1548-1560. 2007
  • Dopamine release is impaired in a mouse model of DYT1 dystonia.  102:783-788. 2007
  • Glutamate production by HIV-1 infected human macrophage is blocked by the inhibition of glutaminase.  102:539-549. 2007
  • Evidence for D2 receptor mediation of amphetamine-induced normalization of locomotion and dopamine transporter function in hypoinsulinemic rats.  101:151-159. 2007
  • Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra.  100:1449-1457. 2007
  • Reduction of methamphetamine-induced sensitization and reward in matrix metalloproteinase-2 and -9-deficient mice.  100:1579-1588. 2007
  • Phosphorylation of the tubulin-binding protein, stathmin, by Cdk5 and MAP kinases in the brain.  99:237-250. 2006
  • Up-regulation of NMDA receptor subunit and post-synaptic density protein expression in the thalamus of elderly patients with schizophrenia.  98:1114-1125. 2006
  • Loss of Usp14 results in reduced levels of ubiquitin in ataxia mice.  95:724-731. 2005
  • Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine.  94:1402-1410. 2005
  • Impairment of hippocampal long-term depression and defective spatial learning and memory in p35-/- mice.  94:917-925. 2005
  • Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stability.  93:502-512. 2005
  • Identification of tyrosine hydroxylase as a physiological substrate for Cdk5.  91:374-384. 2004
  • Accumulation of protein O-GlcNAc modification inhibits proteasomes in the brain and coincides with neuronal apoptosis in brain areas with high c-GlcNAc metabolism.  89:1044-1055. 2004
  • Induction of motor neuron apoptosis by free 3-nitro-L-tyrosine.  89:602-612. 2004
  • Chloroquine induces activation of nuclear factor-κB and subsequent expression of pro-inflammatory cytokines by human astroglial cells.  84:1266-1274. 2003
  • Subcellular segregation of distinct heteromeric NMDA glutamate receptors in the striatum.  85:935-943. 2003
  • The dopamine D1 receptor is a critical mediator for cocaine-induced gene expression.  82:1453-1464. 2002
  • PI 3-kinase regulation of dopamine uptake.  81:859-869. 2002
  • Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: Distinct roles of calcineurin and protein phosphatase-2A.  81:832-841. 2002
  • Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects.  77:916-928. 2001
  • Constitutive α-secretase cleavage of the β-amyloid precursor protein in the furin-deficient LoVo cell line: Involvement of the pro-hormone convertase 7 and the disintegrin metalloprotease ADAM10.  76:1532-1539. 2001
  • Identification and characterization of nuclear factor κB binding sites in the murine bcl-x promoter.  75:1377-1389. 2000
  • Oncostatin M regulation of interleukin-6 expression in astrocytes: Biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38.  75:563-575. 2000
  • Frontal lobe dysfunction in progressive supranuclear palsy: Evidence for oxidative stress and mitochondrial impairment.  74:878-881. 2000
  • Evidence for oxidative stress in the subthalamic nucleus in progressive supranuclear palsy.  73:881-884. 1999
  • Glucocorticoids stimulate inflammatory 5-lipoxygenase gene expression and protein translocation in the brain.  73:693-699. 1999
  • Repeated administration of dexamethasone increases phosphoinositide- specific phospholipase C activity and mRNA and protein expression of the phospholipase C β1 isozyme in rat brain.  73:780-790. 1999
  • Down-regulation of the expression of O-acetyl-GD3 by the O- acetylesterase cDNA in hamster melanoma cells: Effects on cellular proliferation, differentiation, and melanogenesis.  72:954-961. 1999
  • Administration of dexamethasone up-regulates protein kinase C activity and the expression of γ and ε protein kinase C isozymes in the rat brain.  72:380-387. 1999
  • Protected-site phosphorylation of protein kinase C in hippocampal long- term potentiation.  71:1075-1085. 1998
  • The human N-methyl-D-aspartate receptor 2C subunit: Genomic analysis, distribution in human brain, and functional expression.  71:1953-1968. 1998
  • Elevation of cyclic AMP levels in astrocytes antagonizes cytokine- induced adhesion molecule expression.  69:1438-1448. 1997
  • Superoxide dismutase catalyzes nitration of tyrosines by peroxynitrite in the rod and head domains of neurofilament-L.  69:1945-1953. 1997
  • Changes Induced in Astrocyte Cathepsin D by Cytokines and Leupeptin.  57:406-414. 1991
  • Gangliosides in Human Fetal Brain.  56:1763-1768. 1991
  • Glycosphingolipid Glycosyltransferases in Human Fetal Brain.  56:1461-1465. 1991
  • Determination of Gangliosides in Six Human Primary Medulloblastomas.  55:1322-1326. 1990
  • Myelin Basic Protein‐Specific RNA Levels in Interleukin‐2‐Stimulated Oligodendrocytes.  49:1274-1279. 1987
  • Immunohistochemical Localization of Intermediate Filament Proteins of Neuronal and Nonneuronal Origin in the Goldfish Optic Nerve: Specific Molecular Markers for Optic Nerve Structures.  47:1226-1234. 1986
  • Properties of Particulate and Detergent‐Solubilized Phospholipid N‐Methyltransferase Activity from Calf Brain.  38:1404-1412. 1982
  • IDENTIFICATION OF SEROTONIN WITHIN VITAL‐STAINED NEURONS FROM LEECH GANGLIA.  32:1559-1563. 1979
  • Visual deprivation affects serotonin levels in the visual system.  30:1187-1189. 1978
  • International Standard Serial Number (issn)

  • 0022-3042
  • Electronic International Standard Serial Number (eissn)

  • 1471-4159